Hemab
Latest round
- Series C
Last raised
- Oct 2025
Total raised
- $347M
Investors
- 11
About Hemab
Founded in 2019, and based in Frederiksberg, Denmark, Hemab ApS is a biotechnology company dedicated to developing innovative therapeutics for serious bleeding and thrombotic disorders, addressing critical unmet medical needs in patient care.
Who invested in Hemab
11 investors across 3 rounds
See all investors in Hemab
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Hemab
Who invested in Hemab?
Hemab has 11 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Hemab raised?
Hemab has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Hemab last raise money?
Hemab's most recent round on record is a Series C, in Oct 2025.
What does Hemab do?
Founded in 2019, and based in Frederiksberg, Denmark, Hemab ApS is a biotechnology company dedicated to developing innovative therapeutics for serious bleeding and thrombotic disorders, addressing critical unmet medical needs in patient care.
Where is Hemab headquartered?
Hemab is headquartered in Frederiksberg, Denmark.
Which VCs invest in companies like Hemab?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Hemab's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Hemab? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.